22nd Century Group Past Earnings Performance
Past criteria checks 0/6
22nd Century Group's earnings have been declining at an average annual rate of -38.8%, while the Tobacco industry saw earnings growing at 9.7% annually. Revenues have been growing at an average rate of 21% per year.
Key information
-38.8%
Earnings growth rate
-22.8%
EPS growth rate
| Tobacco Industry Growth | 18.1% |
| Revenue growth rate | 21.0% |
| Return on equity | n/a |
| Net Margin | -296.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Market Participants Recognise 22nd Century Group, Inc.'s (NASDAQ:XXII) Revenues Pushing Shares 1,233% Higher
Apr 02
Time To Worry? Analysts Just Downgraded Their 22nd Century Group, Inc. (NASDAQ:XXII) Outlook
Aug 20With 22nd Century Group, Inc. (NASDAQ:XXII) It Looks Like You'll Get What You Pay For
Jun 14Does 22nd Century Group (NASDAQ:XXII) Have A Healthy Balance Sheet?
Jan 1322nd Century adds Creager as distribution partner for its VLN cigarettes in Colorado
Oct 0322nd Century Group to expand sales of VLN tobacco cigarettes
Sep 0722nd Century Group (NASDAQ:XXII) Has Debt But No Earnings; Should You Worry?
Sep 0222nd Century GAAP EPS of -$0.06 in-line, revenue of $14.5M beats by $3.21M
Aug 0922nd Century Group launches $35M securities offering
Jul 21Will 22nd Century Group (NASDAQ:XXII) Spend Its Cash Wisely?
May 1022nd Century Group: Record Revenues On VLN Cigarettes And Cannabis IP
May 09Revenue & Expenses BreakdownBeta
How 22nd Century Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 22 | -65 | 31 | 3 |
| 30 Sep 23 | 84 | -139 | 54 | 7 |
| 30 Jun 23 | 84 | -78 | 57 | 7 |
| 31 Mar 23 | 75 | -69 | 51 | 7 |
| 31 Dec 22 | 28 | -37 | 32 | 4 |
| 30 Sep 22 | 49 | -47 | 39 | 5 |
| 30 Jun 22 | 39 | -44 | 31 | 5 |
| 31 Mar 22 | 30 | -36 | 28 | 4 |
| 31 Dec 21 | 31 | -33 | 26 | 4 |
| 30 Sep 21 | 23 | -25 | 23 | 4 |
| 30 Jun 21 | 25 | -20 | 19 | 4 |
| 31 Mar 21 | 28 | -21 | 17 | 4 |
| 31 Dec 20 | 28 | -20 | 15 | 4 |
| 30 Sep 20 | 28 | -20 | 13 | 4 |
| 30 Jun 20 | 27 | -26 | 14 | 6 |
| 31 Mar 20 | 27 | -29 | 13 | 7 |
| 31 Dec 19 | 26 | -27 | 13 | 8 |
| 30 Sep 19 | 26 | -29 | 11 | 10 |
| 30 Jun 19 | 26 | -13 | 9 | 12 |
| 31 Mar 19 | 27 | -11 | 9 | 15 |
| 31 Dec 18 | 26 | -8 | 9 | 15 |
| 30 Sep 18 | 25 | -3 | 9 | 13 |
| 30 Jun 18 | 24 | -12 | 9 | 9 |
| 31 Mar 18 | 20 | -9 | 9 | 5 |
| 31 Dec 17 | 17 | -13 | 8 | 3 |
| 30 Sep 17 | 14 | -12 | 8 | 3 |
| 30 Jun 17 | 13 | -11 | 7 | 3 |
| 31 Mar 17 | 11 | -11 | 7 | 2 |
| 31 Dec 16 | 12 | -12 | 8 | 2 |
| 30 Sep 16 | 12 | -12 | 8 | 2 |
| 30 Jun 16 | 11 | -12 | 8 | 2 |
| 31 Mar 16 | 11 | -10 | 8 | 2 |
| 31 Dec 15 | 9 | -11 | 9 | 2 |
| 30 Sep 15 | 6 | -14 | 11 | 1 |
| 30 Jun 15 | 3 | -14 | 12 | 1 |
| 31 Mar 15 | 1 | -14 | 12 | 1 |
| 31 Dec 14 | 1 | -16 | 9 | 1 |
| 30 Sep 14 | 8 | -18 | 6 | 1 |
| 30 Jun 14 | 8 | -30 | 4 | 1 |
| 31 Mar 14 | 8 | -29 | 4 | 1 |
| 31 Dec 13 | 7 | -26 | 4 | 1 |
| 30 Sep 13 | 0 | -23 | 4 | 1 |
| 30 Jun 13 | 0 | -8 | 3 | 1 |
Quality Earnings: XXII is currently unprofitable.
Growing Profit Margin: XXII is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: XXII is unprofitable, and losses have increased over the past 5 years at a rate of 38.8% per year.
Accelerating Growth: Unable to compare XXII's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: XXII is unprofitable, making it difficult to compare its past year earnings growth to the Tobacco industry (0.8%).
Return on Equity
High ROE: XXII's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.